Brand Intelligence Graph
Company Overview
About ForSight Robotics
ForSight Robotics is developing the Oryom — a surgical robot designed to reach any anatomical point within the human eye, enabling robotic cataract surgery, retinal procedures, and glaucoma interventions with precision exceeding human capability. The company raised $125 million in Series B financing in June 2025 and is launching its first human cataract trials in 2026, making it one of the most clinically advanced ophthalmic robotics companies globally. If the 2026 trial results are positive, an FDA submission pathway follows for the world's first robotic eye surgery system at clinical scale.
Business Model & Competitive Advantage
Cataract surgery is the highest-volume surgical procedure globally — approximately 28 million procedures annually — and the tremor problem in manual surgery (even experienced surgeons have physiological hand tremor of 50-100 microns) is the primary source of intraoperative complications. Oryom's robotic guidance eliminates this constraint, with sub-micron positioning accuracy enabling surgical maneuvers in the vitreous cavity that human hands cannot reliably execute.
Competitive Landscape 2025–2026
The ophthalmic surgical robotics market is effectively untapped: Intuitive Surgical dominates general laparoscopy but has no ophthalmic product; CMR Surgical and Stryker operate in orthopedic and abdominal surgery. ForSight faces minimal competition from established robotics companies while targeting a surgical volume that dwarfs most other specialties.
Key Differentiators
Emerging Innovator
ForSight Robotics is an emerging player bringing innovative solutions to the MedTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
10x Genomics
10x Genomics was founded in 2012 in Pleasanton, California by Serge Saxonov, Ben Hindson, and Kevin Ness. The company developed the Chromium platform for single-cell RNA sequencing (scRNA-seq), enabli
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Compare ForSight Robotics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from ForSight Robotics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim ForSight Robotics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention ForSight Robotics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →